
Crinetics Pharmaceuticals Email Format
Pharmaceutical Manufacturing
・
501-1,000 employees
・
San Diego, CA, USA
Crinetics Pharmaceuticals is a global pharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for endocrine diseases and endocrine-related tumors.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@crinetics.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
2008
Headquarters
San Diego, CA, USA
Revenue
$250M-$500M
FUNDING Stage
Public
Website
Key Executives
R. Scott Struthers, Ph.D. (Founder & Chief Executive Officer), Tobin Schilke (Chief Financial Officer), Kea Lingo (Chief Information Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals uses the firstinitiallast format, so Jane Smith would be jsmith@crinetics.com.
What approved product does Crinetics Pharmaceuticals currently sell?
Crinetics Pharmaceuticals markets PALSONIFY, an oral once-daily SST2 agonist approved in the US for adults with acromegaly who had an inadequate response to surgery or for whom surgery is not an option.
Which endocrine conditions is Crinetics Pharmaceuticals targeting with its late-stage pipeline candidate atumelnant?
Atumelnant is Crinetics Pharmaceuticals' investigational oral ACTH antagonist being studied in Phase 2/3 trials for congenital adrenal hyperplasia in adults and children, as well as Phase 2 trials for ACTH-dependent Cushing's syndrome.
How large is Crinetics Pharmaceuticals and where is it headquartered?
Crinetics Pharmaceuticals is headquartered at 6055 Lusk Blvd in San Diego, California, and has approximately 598 employees. You can use Clay to build or verify a contact list for the company's team.
Who founded Crinetics Pharmaceuticals and who leads it today?
Crinetics Pharmaceuticals was founded by R. Scott Struthers, Ph.D., who also serves as the company's Chief Executive Officer in 2026. Tobin Schilke serves as Chief Financial Officer.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating


